TrialBMC infectious diseases2011

Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy.

Thomas A Rasmussen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.